The proposed bill amends the existing law on "Collaborative Pharmacy Practice" to broaden the scope of collaborative practice agreements by allowing licensed pharmacists to collaborate not only with physicians but also with other healthcare providers. Key changes include the replacement of the term "physicians" with "providers" throughout the definitions and agreements, thereby expanding the potential for collaboration. Additionally, the bill introduces a new requirement for collaborative practice agreements to be submitted to the board of pharmacy for record-keeping, although it specifies that no approval or denial process will be required. The agreements must be reviewed and signed annually, and any substantive changes impacting patient care must be refiled with the board.

Furthermore, the bill removes the definition of the "collaborative practice committee," which previously consisted of appointed individuals from pharmacy and medical boards to advise on collaborative practice regulations. The immunity provisions for the director of health, board members, and their agents remain intact, protecting them from civil or criminal liability for actions taken in good faith during their official duties. The act is set to take effect on July 1, 2025.